The regulation of human immunodeficiency virus type-1 gene expression

European Journal of Biochemistry

Volumn 240, Issue 3, 1996, Pages 491-507

  Kingsman, Susan M ^a   Kingsman, Alan J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

AIDS; Human immunodeficiency virus type 1; Rev; Tat

Indexed keywords

MESSENGER RNA; REGULATOR PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN RNA BINDING; REVIEW; VIRUS REPLICATION;

CULLEN; EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0029741456     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1996.0491h.x     Document Type: Review

References (177)

1. Cullen, B. R. (1992) Mechanism of action of regulatory proteins encoded by complex retroviuses, Microbiol. Rev. 56, 375-394.
2. Levy, J. A. (1993) Pathogenesis of human immunodeficiency virus infection, Microbiol. Rev. 57, 183-289.
3. Antoni, B. A., Stein, S. & Rabson, A. B. (1994) Regulation of human immunodeficiency virus infection: implications for pathogenesis, Adv. Virus Res. 43, 53-145.
4. Rosen, C. A. & Fenyoe, E. M. (1995) Virology, an overview, AIDS (Phila.) 9, S1-S3.
5. Pantaleo, G. & Fauci, A. S. (1994) Tracking HIV during disease progression, Curr. Opin. Immunol. 6, 600-604.
6. Ullman, K. S., Northrop, J. P., Verweij, C. L. & Crabtree, G. R. (1990) Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link, Ann. Rev. Immunol. 8, 421-452.
7. McLean, A. R. & Michie, C. A. (1995) In vivo estimates of division and death rates of human T lymphocytes, Proc. Natl Acad. Sci. USA 92, 3707-3711.
8. McCune, J. M. (1995) Viral latency in HIV disease, Cell 82, 183-188.
9. Zack, J., Haislip, A. M., Krogstad, P. & Chen, I. S. Y. (1992) Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle, J. Virol. 66, 1717-1725.
10. Spina, C. A., Guatelli, J. & Richman, D. D. (1995) Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro, J. Virol. 69, 2977-2988.
11. Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H. & Orenstein, J. M. (1993) HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease, Nature 362, 355-358.
12. Ho, D. D., Heumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection, Nature 373, 123-126.
13. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer, S., Nowak, M. A., Hahn, B. H., Saag, M. S. & Shaw, G. M. (1995) Viral dynamics in human immunodeficiency virus type 1 infection, Nature 373, 117-122.
14. Coffin, J. M. (1995) HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy, Science 267, 483-489.
15. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. (1996) HIV-1 dynamcis in vivo: virion clearance rate, infected cell life-span, and viral generation time, Science 271, 1582-1585.
16. Trono, D. (1995) HIV accessory proteins: leading roles for the supporting cast, Cell 82, 189-192.
17. Subbramanian, R. A. & Cohen, E. A. (1994) Molecular biology of the human immunodeficiency virus accessory proteins, J. Virol. 68, 6831-6835.
18. Schwartz, S., Felber, B. K., Benko, D. M., Fenyo, E. M. & Pavlakis, G. N. (1990) Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1, J. Virol. 64, 2519-2529.
19. Kim, S., Byrn, R., Groopman, J. E. & Baltimore, D. (1989) Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression, J. Virol. 63, 3708-3713.
20. Pomerantz, F. J., Seshamma, T. & Trono, D. (1992) Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency, J. Virol. 66, 1809-1813.
21. Michael, N. L., Morrow, P., Mosca, J., Vahey, M., Burke, D. & Redfield, R. R. (1991) Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns. J. Virol. 65, 1291-1303.
22. Adams, M., Sharmeen, L., Kimpton, J., Romeo, J. M., Garcia, J. V., Peterlin, B. M., Groudin, M. & Ermerman, M. (1994) Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts, Proc. Natl Acad. Sci. USA 91, 3862-3866.
23. Jowett, J. B. M., Planelles, V., Poon, B., Shah, N. P., Chen, M. L. & Chen, I. S. Y. (1995) The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle, J. Virol. 69, 6304-6313.
24. Refaeli, Y., Levy, D. N. & Weiner, D. B. (1995) The glucocorticoid receptor type 1I complex is a target of the HIV-1 vpr gene product, Proc. Natl Acad. Sci. USA 92, 3621-3625.
25. Chang, H.-K., Gallo, R. C. & Ensoli, B. (1995) Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 tat protein, J. Biomed. Sci. 2, 189-202.
26. Li, C. J., Friedman, D. J., Wang, C., Metelev, V. & Pardee, A. B. (1995) Induction of apoptosis in unifected lymphocytes by HIV-1 Tat protein, Science 268, 429-431.
27. Jones, K. A. (1993) Tat and the HIV-1 promoter, Curr. Opin. Cell Biol. 5, 461-468.
28. Kao, S. Y., Calman, A. F., Luciw, P. A. & Peterlin, B. M. (1987) Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product. Nature 330, 489-493.
29. Feinberg, M. B., Baltimore, D. & Frankel, A. D. (1991) The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation, Proc. Natl Acad. Sci. USA 88, 4045-4049.
30. Alonso, A., Cujec, T. P. & Peterlin, M. (1994) Effects of human chromosome 12 on interactions between tat and TAR of human immunodeficiency virus type 1, J. Virol. 68, 6505-6513.
31. Braddock, M. Chambers, A., Wilson, W., Esnouf, M. P., Adams, S. E., Kingsman, A. J. & Kingsman, S. M (1989) HIV-1 TAT 'activates' presynthesized RNA in the nucleus, Cell 58, 269-279.
32. Marciniak, R. & Sharp, P. A. (1991) HIV-1 Tat protein promotes formation of more processive elongation complexes, EMBO J. 10, 4189-4196.
33. Laspia, M. F., Rice, A. & Mathews, M. B. (1989) HIV-1 Tat protein increases transcriptional intitation and stabilizes elongation, Cell 59, 283-292.
34. Rosen, C. A., Sodroski, J., Goh, W. C., Dayton, A. I., Lippke, J. & Haseltine, W. (1986) Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type 1II, Nature 319, 555-559.
35. Cullen, B. R. (1986) Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism, Cell 46, 973-982.
36. Yankulov, K., Blau, J., Purton, T., Roberts, S. & Bentley, D. L. (1994) Transcriptional elongation by RNA polymerase II is stimulated by transactivators, Cell 77, 749-759.
37. Valerie, K., Delers, A., Bruck, C., Thiriart, C., Rosenberg, H., Debouck, C. & Rosenberg, M. (1988) Activation of human immunodeficiency virus type 1 by DNA damage in human cells, Nature 333, 78-81.
38. Harrich, D., Hsu, C., Race, E. & Gaynor, R. B. (1994) Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants, J. Virol. 68, 5899-5910.
39. Greenblatt, J., Nodwell, J. R. & Mason, S. W. (1993) Transcriptional antitermination, Nature 364, 401-406.
40. Lee, H.-S., Kraus, K. W., Wolfner, M. F. & Lis, J. T. (1992) DNA sequence requirements for generating paused polymerase at the start of hsp70. Genes & Dev. 6, 284-295.
41. Hernandez, N. & Lucito, R. (1988) Elements required for transcription initiation of the human U2 snRNA gene coincide with elements required for snRNA3′ end formation, EMBO J. 7, 3125-3134.
42. Spencer, C. A. & Groudine, M. (1990) Transcription elongation and eucaryotic gene regulation, Oncogene 5, 777-785.
43. Graeble, M. A., Churcher, M. J., Lowe, A. D., Gait, M. J. & Karn, J. (1993) Human immunodeficiency virus type 1 transactivator protein,tat, stimulates transcriptional read-though of distal terminator sequences in vitro, Proc. Natl Acad. Sci. USA 90, 6184-6188.
44. Wright, S., Lu, X. & Peterlin, B. M. (1994) Human immunodeficiency virus type 1 tat directs transcription through attenuation sites within the mouse c-myc gene, J. Mol. Biol. 243, 568-573.
45. Ratnasabapathy, R., Sheldon, M., Johal, L. & Hernandez, N. (1990) The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters, Genes & Dev. 4, 2061-2074.
46. Selby, M. J., Bain, E. S., Luciw, P. A. & Peterlin, B. M. (1989) Structure, sequence, and position of the stem-loop in TAR determine transcriptional elongation by Tat through the HIV-1 long terminal repeat, Genes & Dev. 3, 547-558.
47. Cullen, B. R. (1993) Does HIV-1 tat induce a change in viral initiation rights? Cell 73, 417-420.
48. Sheldon, M., Ratnasabapathy, R. & Hernandez, N. (1993) Characterization of the inducer of short transcripts, a human immunodeficiency virus type 1 transcriptional element that activates the sysnthesis of short RNAs, Mol. Cell. Biol. 13, 1251-1263.
49. Sullenger, B. A., Gallardo, H. F., E. U. G. & Gilboa, E. (1991) Analysis of transacting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation, J. Virol. 65, 6811-6816.
50. Lisziewicz, J., Sun, D., Smythe, J., Lusso, P., Lori, F., Louie, A., Markham, P., Rossi, J., Reitz, M. & Gallo, R. C. (1993) Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS, Proc. Natl Acad. Sci. USA 90, 8000-8004.
51. Lu, X., Heimer, J., Rekosh, D. & Hammarskjoeld, M. L. (1990) U1 small nuclear RNA plays a direct role in the formation of a Rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc. Natl Acad. Sci. USA 87, 7598-7602.
52. Demarchi, F., D'Agaro, P., Falaschi, A. & Giacca, M. (1993) In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the king terminal repeat of human immunodeficiency virus type 1, J. Virol. 67, 7450-7460.
53. Gaynor, R. B. (1995) Regulation of HIV-1 gene expression by the transactivator protein tat, in Transacting functions of human retroviruses (Srinivasan, A. & Vogt, P. K., eds) pp. 51-77, Springer-Verlag, Heidelberg.
54. Fagagna D'Adda di, F., Marzio, G., Gutierrex, M. I., Kang, L. Y., Falaschi, A. & Giacca, M. (1995) Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1, J. Virol. 69, 2765-2775.
55. Lee, M.-O., Hobbs, P. D., Zhang, X.-K., Dawson, M. I. & Pfahl, M. (1994) A synthetic retinoid antagonist inhibits the human immunodeficiency virus type 1 promoter, Proc. Natl Acad. Sci. USA 91, 5632-5636.
56. Gunkel, N., Braddock, M., Thorburn, A. M., Muckenthaler, M., Kingsman, A. J. & Kingsman, S. M. (1995) Promoter control of translation in Xenopus oocytes, Nucleic Acids Res. 23, 405-412.
57. Nabel, G. & Baltimore, D. (1987) An inducible transcription factor activates expression of human immunodeficiency virus in T-cells, Nature 326, 711-713.
58. Seeler, J.-S., Muchardt, C. Suessle, A. & Gaynor, R. B. (1994) Transcription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expression, J. Virol. 68, 1002-1009.
59. Taylor, J. P., Kundu, M. & Khalili, K. (1993) TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat, Virology 195, 780-785.
60. Baeuerle, P. A. & Henkel, T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-591.
61. Leonard, J., Parrott, C., Buckler-White, J., Turner, W., Ross, E. K., Martin, M. A. & Rabson, A. B. (1989) The NF-κB binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity, J. Virol. 63, 4919-4924.
62. Alcami, J., Lain de Lera, T., Fogueira, L., Pedraza, M. A., Jacque, J. M., Bachelerie, F., Noriega, A. R., Hay, R. T., Harrich, D., Gaynor, R. B., Virelizier, J. L. & Arenzana-Seisdedos, F. (1995) Absolute dependence on kappa-B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes, EMBO J. 14, 1552-1560.
63. Moses, A. V., Ibanez, C., Gaynor, R., Ghazal, P. & Nelson, J. A. (1994) Differential role of long terminal repeat control elements for the regulation of basal and tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages, J. Virol. 68, 298-307.
64. White, M., Masuko, M., Amet, L., Elliott, G., Braddock, M., Kingsman, A. J. & Kingsman, S. M. (1995) Real lime analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells, J. Cell Sci. 108, 441.
65. Southgate, C. M. & Green, M. R. (1991) Tat protein activates transcription from an upstream DNA binding site: implications for tat function, Genes & Dev. 5, 2496-2507.
66. Madore, S. J. & Cullen, B. R. (1995) Functional similarities between HIV-1 tat and DNA sequence-specific transcriptional activators, Virology 206, 1150-1154.
67. Sune, C. & Garcia-Blanco, M. (1995) Sp1 transcription factor is required for in vitro basal and tat-activated transcription from the human immunodeficiency virus type 1 long terminal repeat, J. Virol. 69, 6572-6576.
68. Huang, L. M. & Jeang, K.-T. (1993) Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function, J. Virol. 67, 6937-6944.
69. Buratowski, S. (1994) The basics of basal transcription by RNA polymerase 11, Cell 77, 1-3.
70. Tjian, R. & Maniatis, T (1994) Transcriptional activation: A complex puzzle with few easy pieces, Cell 77, 5-8.
71. Ou, S.-H. I., Garcia-Martinez, L. F., Paulssen, E. J. & Gaynor, R. B. (1994) Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function, J. Virol. 68, 7188-7199.
72. Olsen, H. S. & Rosen, C. (1992) Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression, J. Virol. 66, 5594-5597.
73. Berkhout, B. & Jeang, K.-T. (1992) Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat, J. Virol. 66, 139-149.
74. Lu, X., Welsh, T. M. & Peterlin, M. (1993) The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by tat, J. Virol. 67, 1752-1760.
75. Sune, C. & Garcia-Blanco, M. A. (1995) Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors, J. Virol. 69, 3098-3107.
76. Roy, A. L., Meisterernst, M., Pognonec, P. & Roeder, R. G. (1991) Cooperative interaction of an initiator binding transcription initiation factor and the helix-loop-helix activator USF, Nature 354, 245-248.
77. Zenzie-Gregory, B., Sheridan, P., Jones, K. A. & Smale, S. T. (1993) HIV-1 core promoter lacks a simple initiator element but contains a bipartite activator at the transcription start site, J. Biol. Chem. 268, 15823-15832.
78. Du, H., Roy, A. L. & Roeder, R. G. (1993) Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters, EMBO J. 12, 501-511.
79. Guo, B., Odgren, P. R., Wijnen, V. A. J. & Last, T. J., Nickerson, J., Penman, S., Lian, J. B., Stein, J. L. & Stein, G. S. (1995) The nuclear matrix protein NMP-1 is the transcription factor YY1, Proc. Natl Acad. Sci. USA 92, 10526-10530.
80. Margolis, D. M., Somasundaran, M. & Green, M. R. (1994) Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production, J. Virol. 68, 905-910.
81. Ou, S.-H. I., Wu, F., Harrich, D., Garcia-Martinez, L. F. & Gaynor, R. B. (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs, J. Virol. 69, 3584-3596.
82. Parada, C. A., Yoon, J.-B. & Roeder, R. G. (1995) A novel LBP-1 mediated restruction of HIV-1 transcription at the level of elongation in vitro, J. Biol. Chem. 270, 2274-2283.
83. Klaver, B. & Berkhout, B. (1994) Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus, EMBO J. 13, 2650-2659.
84. Duan, L., Ozaki, I., Oakes, J. W., Taylor, J. P., Khalili, K. & Pomerantz, R. J. (1994) The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication, J. Virol. 68, 4302-4313.
85. Valerie, K. & Rosenberg, M. (1990) Chromatin structure implicated in activation of HIV-1 gene expression by ultraviolet light, New Biol. 2, 712-718.
86. Verdin, E., Paras, P. & VanLint, C. (1993) Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation, EMBO J. 12, 3249-3259.
87. Gait, M. J. & Karn, J. (1993) RNA recognition by the human immuno-deficiency virus Tat and Rev proteins, Trends Biochem. Sci. 18, 255-259.
88. Tao, J. & Frankel, A. D. (1993) Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus tat proteins, Proc. Natl Acad. Sci. USA 90, 1571-1575.
89. Derse, D., Carvalho, M., Carroll, R. & Peterlin, B. M. (1991) A minimal lentivirus Tat, J. Virol. 65, 7012-7015.
90. Churcher, M. J., Lamont, C., Hamy, F., Dingwall, C., Green, S. M., Lowe, A. D., Butler, P. J. G., Gait, M. J. & Kara, J. (1993) High affinity binding of TAR RNA by the human immunodeficiency virus Type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region, J. Mol. Biol. 230, 90-110.
91. Mujeeb, A., Bishop, K., Peterlin, B. M., Turck, C., Parslow, T. G. & James, T. L, (1994) NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat, Proc. Natl Acad. Sci. USA 91, 8248-8252.
92. Willbold, D., Rosin-Arbesfeld, R., Sticht, H., Frank, R. & Rosch, P. (1994) Structure of the equine infectious anemia virus tat protein, Science 264, 1584-1587.
93. Tan, R. & Frankel, A. D. (1995) Structural variety of arginine-rich RNA-binding peptides, Proc. Natl Acad. Sci. USA 92, 5282-5286.
94. Jaeger, J. A. & Tinoco, I. (1993) An NMR study of the HIV-1 TAR element hairpin, Biochemistry 32, 12522-12530.
95. Critchley, A. D., Haneef, I., Cousens, D. J. & Stockley, P. G. (1993) Modeling and solution structure probing of the HIV-1 TAR stem-loop, J. Mol. Graphics 11, 92-97.
96. Riordan, F. A., Bhattacharyya, A.,. McAteer, S. & Lilley, D. M. J. (1992) Linking of RNA helices by bulged bases, and the structure of the human immunodeficiency virus transactivator response element, J. Mol. Biol. 226, 305-310.
97. Weeks, K. M. & Crothers, D. M. (1991) RNA recognition by Tat-derived peptides: interaction in the major groove, Cell 66, 577-588.
98. Hamy, F., Asseline, U., Grasby, J., Shigenori, I., Pritchard, C., Slim, G., Butler, P. J. G., Karn, J. & Gait, M., J. (1993) Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus Type-1 tat protein recognition of TAR RNA, J. Mol. Biol. 230, 111-123.
99. Calnan, B. J., Biancalan, S., Hudson, D. & Frankel. A. D. (1991) Analysis of argininge-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition, Genes & Dev. 5, 201-210.
100. Puglisi, J. D., Chen, L., Frankel, A. D. & Williamson, J. R. (1993) Role of RNA structure in arginine recognition of TAR RNA, Proc. Natl Acad. Sci. USA 90, 3680-3684.
101. Long, K. S. & Crothers, D. M. (1995) Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA, Biochemistry 34, 8885-8895.
102. Blanchard, A. D., Powell, R., Braddock, M., Kingsman, A. J. & Kingsman, S. M. (1992) An adenosine at position 27 in the human immunodeficiency virus type 1 trans-activation response element is not critical for transcriptional or translational activation by Tat, J. Virol. 66, 6769-6772.
103. Delling, U., Reid, L. S., Barnett, R. W., Ma, M. Y.-X., Climie, S., Summer-Smith, M. & Sonenberg, N. (1992) Conserved nucleotides in the TAR RNA stem of human immunodeficiency virus type 1 are critical for Tat binding and trans activation: model for TAR RNA tertiary structure, J. Virol. 66, 3018-3025.
104. Feng, S. & Holland, E. C. (1988) HIV-1 tat transactivation requires the loop sequences within TAR, Nature 334, 165-167.
105. Roy, S., Parkin, N. T., Rosen, C., Itovitch, J. & Sonenberg, N. (1990) Structural requirements of transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequences and bulges in the tat-responsive region, J. Virol. 64, 1402-1406.
106. Berkhout, B. & Jeang, K.-T. (1991) Detailed muational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains, Nucleic Acids Res. 19, 6169-6176.
107. Braddock, M., Powell, R., Sutton, J., Kingsman, A. J. & Kingsman, S. M. (1994) Orientation specific cis complementation by bulge- and loop mutated human immunodeficiency virus type 1 TAR RNAs, J. Virol. 68, 8396-8400.
108. Sutton, J. A., Braddock, M., Kingsman, A. J. & Kingsman, S. M. (1995) Requirement for HIV-1 TAR sequences for Tat activation in rodent cells, Virology 206, 690-694.
109. Madore, S. J. & Cullen, B. R. (1993) Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function, J. Virol. 67, 3703-3711.
110. Braddock, M., Powell, R., Blanchard, A. D., Kingsman, A. J. & Kingsman, S. M. (1993) HIV-1 TAR RNA-binding proteins control Tat activation of translation in Xenopus oocytes, FASEB J. 7, 214-222.
111. Sheline, T., Milocco, L. H. & Jones, K. A. (1991) Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin, Genes & Dev. 5, 2508-2520.
112. Gatignol, A., Buckler, C. & Jeang, K.-T. (1993) Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsI kinase and Drosophila staufen, Mol. Cell. Biol. 13, 2193-2202.
113. Cosentino, G. P., Venkatesan, S., Serluca, F. C., Green, S. R., Mathews, M. B. & Sonenherg, N. (1995) Double-stranded-RNA dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo, Proc. Natl Acad. Sci. USA 92, 9445-9449.
114. Kozak, C. A., Gatignol, A., Graham, K., Jeang, K. T. & McBride, O. W. (1995) Genetic mapping in human and mouse of the locus encoding TRBP, a protein that binds the TAR region of the human immunodeficiency virus (HIV-1), Genomics 25, 66-72.
115. Baker, B., Muckenthaler, M., Blanchard, A. D., Vives, E., Braddock, M. Nacken, W., Kingsman, A. J. & Kingsman, S. M. (1994) Identification of a novel HIV-1 RAR RNA bulge binding protein, Nucleic Acids Res. 22, 3365.
116. Reddy, T. R., Suhasini, M., Rappaport, J., Looney, D. J., Kraus, G. & Wong-Staal, F. (1995) Molecular cloning and characterization of a TAR-binding nuclear factor from T cells, AIDS Res. Hum. Retroviruses 11, 663-669.
117. Wu, F. J., Garcia, D. Sigman, D. & Gaynor, R. (1991) Tat regulates binding of the human immunodeficiency virus transactivating region RNA loop-binding protein TRP-185, Genes & Dev. 5, 2128-2140.
118. Wu-Baer, F., Lane, W. S. & Gaynor, R. B. (1995) The cellular factor TRP-185 regulates RNA polymerase II binding to HIV-1 TAR RNA, EMBO J. 14, 5995-6009.
119. Hart, C. E., Saltarelli, M. M. J., Galphin, J. C. & Schochetman, G. (1995) A human chromosome 12 associated 83 kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA, J. Virol. 69. 6593-6599.
120. Marciniak, R. A., Garcia-Blanco, M. A. & Sharp, P. A. (1990) Identification and characterisation of a Hela nuclear protein that specifically binds to the transactivation response element of human immunodeficiency virus, Proc. Natl Acad. Sci. USA 87, 3624-3628.
121. Chang, Y.-N., Kenan, D. J., Keene, J. D., Gatignol, A. & Jeang, K.-T. (1994) Direct interactions between autoantigen La and Human immunodeficiency virus leader RNA, J. Virol. 68, 7008-7020.
122. Han, X.-M., Laras, A., Rounseville, M. P., Kumar, A. & Shank, P. R. (1992) Human immunodeficiency virus type 1 tat-mediated trans activation correlates with the phosphorylation state of a cellular TAR RNA stem-binding factor, J. Virol. 66, 4065-4072.
123. Carrier, K. Gatignol, A., Hollander, M. C. & Jeang, K.-T. (1994) Induction of RNA-binding proteins in mammalian cells by DNA-damaging agents, Proc. Natl Acad. Sci. USA 91, 1554-1558.
124. Kozak, M. (1994) Features in the 5′ non-coding sequences of rabbit alpha and beta-globin mRNAs that affect translational efficiency, J. Mol. Biol. 235, 95-110.
125. SenGupta, D. N., Berkhout, B., Gatignol, A., Zhou, A. & Silverman, R. H. (1990) Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1, Proc. Natl Acad. Sci. USA 87, 7492-7496.
126. Parkin, N. T. Cohen, E. A., Darveau, A., Rosen, C., Haseltine, W. & Sonenberg, N. (1988) Mutational analysis of the 5′ non-coding region of human immunodeficiency virus type 1: effects of secondary structure on translation, EMBO J. 7, 2831-2837.
127. Edery, I., Petryshyn, R. & Sonenberg, N. (1989) Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 messenger RNA: A novel translational control mechanism, Cell 56, 303-312.
128. Gunnery, S., Greeen, S. R. & Mathews, M. B. (1990) Tat responsive region of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: relationship between structure and function, Proc. Natl Acad. Sci. USA 89, 11556-11561.
129. Svitkin, Y. V. Pause, A. & Sonenberg, N. (1994) La autoantigen alleviates translational repression by the 5′ leader sequence of the human immunodeficiency virus type 1 mRNA, J. Virol. 68, 7001-7007.
130. Chin, D. J., Selby, M. J. & Peterlin, B. M. (1991) Human immunodeficiency virus type 1 tat does not transactivate mature transacting responsive region RNA species in the nucleus or cytoplasm of primate cells, J. Virol. 65, 1758-1764.
131. Kamine, J., Subramanian, T. & Chinnadurai, G. (1993) Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators, J. Virol. 67, 6828-6834.
132. Song, C.-Z., Loewenstein, P. M. & Green, M. (1994) Transcriptional activation in vitro by the human immunodeficiency virus type 1 Tat protein: evidence for specific interaction with a co-activator(s), Proc. Natl Acad. Sci. USA 91, 9357-9361.
133. Zhou, Q. & Sharp, P. A. (1995) Novel mechanism and factor for regulation by HIV-1 Tat, EMBO J. 14, 321-328.
134. Kashanchi, F., Piras, G., Radonovich, M. F., Duvall, J. F., Fattaey, A., Chiang, C. M., Roeder, R. G. & Brady, J. N. (1994) Direct interaction of human TFIID with the HIV-1 transactivator Tat, Nature 167, 295-299.
135. Selby, M. J. & Peterlin, M. B. (1990) Transactivation by HIV-1 tat via a heterologous RNA-binding protein, Cell 62, 769-776.
136. Jeang, K.-T., Chun, R., Lin, N. H., Gatignol, A., Glabe, C. G. & Fan, H. (1993) In vitro and in vivo binding of human immunodeficiency virus type 4 Tat protein and Sp1 transcription factor, J. Virol. 67, 6224-6233.
137. Kato, H. M., Sumimoto, H., Pognonec, P., Chen, C.-H., Rosen, C. A. & Roeder, R. G. (1992) HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors, Genes & Dev. 6, 655-666.
138. Yu, L., Zhang, Z., Loewenstein, P. M., Desai, K., Tang, Q., Mao, D., Symington, J. S. & Green, M. (1995) Molecular cloning and characterization of a cellular protein that interacts with the human immunodeficiency virus type 1 Tat transactivator and encodes a strong transcriptional activation domain, J. Virol. 69, 3007-3016.
139. Herrmann, C. H. & Rice, A. (1995) Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor, J. Virol. 69, 1612-1620.
140. O'Brien, T., Hardin, S., Greenleaf, A. & Lis, J. T. (1994) Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation, Nature 370, 75-77.
141. Modesti, N., Garcia, J., Debouck, C., Peterlin, M. & Gaynor, R. (1991) Trans-dominant tat mutants with alterations in the basic domain inhibit HIV-1 gene expression, New Biol. 3, 759-768.
142. Fridell, R. A., Harding, L. S., Bogerd, H. P. & Cullen, B. R. (1995) Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral tat proteins, Virology 209, 347-357.
143. Ohana, B., Moore, P. A., Ruben, S. M., Southgate, C. D., Green, M. R. & Rosen, C. A. (1993) The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes, Proc. Natl Acad. Sci. USA 90, 138-142.
144. Drysdale, C. M. & Pavlakis, G. N. (1991) Rapid activation and subsequent down-regulation of the human immunodeficiency virus type 1 promoter in the presence of Tat: possible mechanisms contributing to latency, J. Virol. 65, 3044-3051.
145. Hsu, M.-C., Dhingra, U., Early, J. V., Holly, M., Keith, D., Nalin, C. M., Richou, A. R., Schutt, A. D., Tam, S. Y., Potash, M. J., Volsky, D. J. & Richman, D. D. (1993) Inhibition of type 1 human immunodeficiency virus replication by a Tat antagonist to which the virus remains sensitive after prolonged exposure in vitro, Proc. Natl Acad. Sci. USA 90, 6395-6399.
146. Braddock, M., Cannon, P., Muckenthaler, M., Kingsman, A. J. & Kingsman, S. M. (1994) Inhibition of human immunodeficiency virus type 1 Tat-dependent activation for translation in Xenopus oocytes by the benzodiazepine Ro24-7429 requires transactivation response element loop sequences, J. Virol. 68, 25-33.
147. Braddock, M., Thorburn, A. M., Kingsman, A. J. & Kingman, S. M. (1991) Blocking of Tat-dependent HIV-1 RNA modification by an inhibitor of RNA polymerase II processivity, Nature 350, 439-441.
148. Stutz, F. & Rosbash, M. (1994) A functional interaction between Rev and yeast pre-mRNA in the nucleus, EMBO J. 13, 4096-4104.
149. Fisher, U., Meyer, S., Teufel, M., Heckel, C., Luhrmann, R. & Rautmann, G. (1994) Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA, EMBO J. 13, 4105-4112.
150. Chang, D. D. & Sharp, P. A. (1989) Regulation by HIV Rev depends upon recognition of splice sites, Cell 59, 789-795.
151. Cullen, B. R. (1995) Regulation of HIV gene expression, AIDS (Phila.), Supplement A: A Year in Review 9, S19-S32.
152. Schwartz, S., Felber, B. K. & Pavlakis, G. N. (1992) Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein, J. Virol. 66, 150-159.
153. Malim, M. H. & Cullen, B. R. (1993) Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes, Mol. Cell. Biol. 13, 6180-6189.
154. Malim, M. H. & Cullen, B. R. (1991) HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency, Cell 65, 241-248.
155. Heaphy, S., Finch, J., Gait, M. J., Karn, J. & Singh, M. (1991) Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich 'bubble' located within the rev-responsive region of viral mRNAs, Proc. Natl Acad. Sci. USA 88, 7366-7370.
156. Bartel, D. P., Zapp, M. L., Green, M. R. & Szostak, J. W. (1991) HIV-1 rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA, Cell 67, 529-536.
157. Battiste, J. L., Tan, R., Frankel, A. D. & Williamson, J. R. (1994) Binding of an HIV Rev peptide to Rev responsive element RNA induces formation of purine-purine base pairs, Biochemistry 33, 2741-2747.
158. Peterson, R. D., Bartel, D. P., Szostak, J. W., Horvath, S. J. & Feigon, J. (1994) 1H NMR studies of the high-affinity Rev binding site of the Rev responsive element of HIV-1 mRNA: base pairing in the core binding element, Biochemistry 33, 5357-5366.
159. Meyer, B. E. & Malim, M. H. (1994) The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm, Genes & Dev. 8, 1538-1547.
160. Fritz, C. C., Zapp, M. L. & Green, M. R. (1995) A human nucleoporin-like protein that specifically interacts with HIV Rev, Nature 376, 530.
161. Stutz, F., Neville, M. & Rosbash, M. (1995) Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 rev protein in yeast, Cell 82, 495-506.
162. Bogerd, H. P., Fridell, R. A., Madore, S. & Cullen, B. R. (1995) Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins, Cell 82, 485-494.
163. Fischer, U., Huber, J., Boelens, W. C., Mattaj, I. W. & Luhrmann, R. (1995) The HIV-1 rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs, Cell 82, 475-483.
164. Luo, Y., Yu, H. & Peterlin, B. M. (1994) Cellular protein modulates effects of human immunodeficiency virus type 1 Rev, J. Virol. 68, 3850-3856.
165. Ruhl, M., Himmelspach, M., Bahr, G. M., Hammerschmid, F., Jaksche, H., Wolff, B., Aschauer, H., Farrington, G. K., Probst, H., Bevec, D. & Hauber, J. (1993) Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 rev activation domain mediating trans-activation, J. Cell Biol. 123, 1309-1320.
166. Elliott, D., Stutz, F., Lescure, A. & Rosbash, M. (1994) mRNA nuclear export, Curr. Opin. Genet. Dev. 4, 305-309.
167. Legrain, P. & Rosbash, M. (1989) Some cis and trans-acting mutants for splicing target pre-mRNA to the cytoplasm, Cell 57, 573-583.
168. Arrigo, S. & Chen, I. S. Y. (1991) Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and enby vol. pu 2 RNAs,
169. Lawrence, J., Cochrane, A., Johnson, C. V., Perkins, A. & Rosen, C. A. (1991) The HIV-1 rev protein: A model system for coupled RNA transport and translation, New Biol. 3, 1220-1232.
170. Bray, M., Prasad, S., Dubay, J. W., Hunter, E., Jeang, K.-T. & Rekosh, D., Hammerskjold, M.-L. (1994) A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent, Proc. Natl Acad. Sci. USA 91, 1256-1260.
171. Cupelli, L. A. & Hsu, M.-C. (1995) The human immunodeficiency virus type 1 tat antagonist, Ro 5 - 3335, predominantly inhibits transcription initiation from the viral promoter, J. Virol. 69, 2640-2643.
172. Zapp, M. L., Stern, S. & Green, M. R. (1993) Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production, Cell 74, 969-978.
173. Biswas, D. K., Ahlers, C. M., Dezube, B. J. & Pardee, A. B. (1993) Cooperative inhibition of NF-κB and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat, Proc. Natl Acad. Sci. USA 90, 11044-11048.
174. Malim, M. G., Bohnlein, S., Hauber, J. & Cullen, B. R. (1989) Functional dissection of the HIV-1 rev trans-activator-derivation of a trans-dominant repressor of rev function, Cell 58, 205-214.
175. Mhashilkar, A. M., Bagley, J., Chen, S. Y. Szilvay, A. M. Helland, D. G. & Marasco, W. A. (1995) Inhibition of HIV-1 Tat-mediated transactivation and HIV-1 infection by anti-Tat single chain intrabodies, EMBO J. 14, 1542-1551.
176. Lever, A. M. L. (1995) Gene therapy for HIV infection, Br. Med. Bull. 1995, 149-166.
177. Pfeifer, K., Bachmann, M., Schroder, H. C., Weiler, B. E., Ugarkovic, D., et al. (1991) Formation of a small ribonucleoprotein particle between tat protein and trans-acting response element in human immunodeficiency virus-infected cells, J. Biol. Chem. 266, 14620-14626.